REG - Abbott Laboratories - Statement of changes in Director/PDMR Shareholding <Origin Href="QuoteRef">ABT.N</Origin>

Abbott LaboratoriesAnnouncement

01/04/2016 12:49

RNS Number : 8155L
Abbott Laboratories
13 January 2016
Notification to RNS
Company:  Abbott Laboratories
TIDM: ABT
Headline:  Abbott Laboratories Files Forms 3 and 4
Abbott Laboratories (the "Company")
13 January 2016
Abbott Laboratories Files Forms 3 and 4
The Company informs its shareholders that on 13 January, 2016, in accordance with Section 16(a) of the U.S. Securities Exchange Act of 1934, as amended, a Form 3 (Initial Statement of Beneficial Ownership of Securities) and a Form 4 (the report on Form 4 being a statement of changes in the beneficial ownership of its officers, directors and 10% owners) ("Form 4") were filed with the U.S. Securities and Exchange Commission ("SEC"). The Forms 3 and 4 can be found on the SEC website at http://www.sec.gov.
A copy of the Forms 3 and 4 have been submitted to the National Storage Mechanism on the date of this announcement and is, or will shortly be, available for inspection at http://www.morningstar.co.uk/uk/NSM.
Issued by: Abbott Laboratories
CONTACT: Financial: Scott Leinenweber, +1-224-668-0791, Michael Comilla, +1-224-668-1872, or Jeffrey Byrne, +1-224-668-8808, or Media: Scott Stoffel, +1-224-668-5201, or Elissa Maurer, +1-224-668-3309.

This information is provided by RNS
The company news service from the London Stock Exchange
  END
RDSEAAFDFALKEAF